Aclaris Therapeutics, Inc. - FORM 10-K - EX-23.1 - March 23, 2016

Attached files

file filename
EX-32.1 - EX-32.1 - Aclaris Therapeutics, Inc.acrs-20151231ex321c212f2.htm
EX-31.2 - EX-31.2 - Aclaris Therapeutics, Inc.acrs-20151231ex312c7251f.htm
10-K - 10-K - Aclaris Therapeutics, Inc.acrs-20151231x10k.htm
EX-31.1 - EX-31.1 - Aclaris Therapeutics, Inc.acrs-20151231ex311bdcb20.htm

EXHIBIT 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on S-8  (No. 333-207434) of our report dated March 23, 2016 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

 

Philadelphia,  Pennsylvania

March 23, 2016

 

Aclaris Therapeutics, Inc. Reports